Theravance Biopharma, Inc. (TBPH)

20.34 +0.33 (+1.65%) USD  |  NASDAQ  |  Jan 20, 14:23
More

Theravance Biopharma EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade